Today: 7 February 2026
Subscribe
Browse Category

Pharmaceuticals News 17 January 2026 - 19 January 2026

Roche stock price slips in Zurich as tariff shock shakes markets — what investors watch next

Roche stock price slips in Zurich as tariff shock shakes markets — what investors watch next

Roche Holding’s non-voting equity securities fell 0.6% to 346.80 francs Monday, just below their one-year high. The drop followed global stock declines after U.S. President Donald Trump threatened tariffs on eight European nations. Investors shifted into the Swiss franc and yen. Roche will report full-year 2025 results on Jan. 29 before the market opens.
19 January 2026
····
AbbVie stock price: ABBV heads into Tuesday with epcoritamab trial in the crosshairs

AbbVie stock price: ABBV heads into Tuesday with epcoritamab trial in the crosshairs

AbbVie shares fell 1.1% to $214.35 after its blood cancer drug epcoritamab failed to show a clear overall-survival benefit in a late-stage trial. U.S. stock and bond markets were closed Monday for Martin Luther King Jr. Day. Investors are awaiting AbbVie’s Feb. 4 earnings for updated 2026 guidance.
19 January 2026
······
Eli Lilly stock set for Tuesday spotlight as new obesity-pill data ripples through GLP-1 trade

Eli Lilly stock set for Tuesday spotlight as new obesity-pill data ripples through GLP-1 trade

Eli Lilly shares rose 0.5% to $1,038.40 Friday, ahead of a holiday-shortened week. Traders are watching early U.S. prescription numbers for Novo Nordisk’s new oral Wegovy, which logged 3,071 scripts in its debut, just below Lilly’s Zepbound. U.S. markets reopen Tuesday, with investors eyeing fresh demand signals and pricing risks. About 3.8 million Lilly shares traded Friday.
19 January 2026
····
Novo Nordisk Class B stock jumps — Wegovy pill scripts and UK dose nod set up the week ahead

Novo Nordisk Class B stock jumps — Wegovy pill scripts and UK dose nod set up the week ahead

Novo Nordisk Class B shares jumped 6.49% in Copenhagen Friday, closing at 388.9 crowns after strong early demand for its once-daily Wegovy pill in the U.S. Britain approved a higher 7.2 mg weekly dose of semaglutide for certain patients. U.S.-listed ADRs rose 9% to $62.33. Novo reports full-year results Feb. 4.
18 January 2026
·······
Novartis stock price: NOVN ends higher on FDA Breakthrough tag for Sjögren’s drug ianalumab — what to watch next week

Novartis stock price: NOVN ends higher on FDA Breakthrough tag for Sjögren’s drug ianalumab — what to watch next week

Novartis shares closed up nearly 1% at 115.60 francs in Zurich after U.S. regulators granted Breakthrough Therapy status to its Sjögren’s disease drug candidate, ianalumab. The Swiss Market Index fell 0.47%. Novartis plans global submissions for ianalumab in early 2026. U.S. markets will be closed Monday for Martin Luther King Jr. Day.
18 January 2026
····
AbbVie stock slides after Epkinly trial misses survival goal — what ABBV investors watch next

AbbVie stock slides after Epkinly trial misses survival goal — what ABBV investors watch next

AbbVie shares fell 1.1% to $214.35 Friday after partner Genmab said their blood cancer drug epcoritamab failed to meet the main survival goal in a Phase 3 trial. Genmab’s U.S. shares dropped over 7%. AbbVie reported a benefit for progression-free survival but not overall survival. Investors await AbbVie’s earnings report on Feb. 4.
18 January 2026
·······
Novo Nordisk stock jumps on Wegovy pill prescriptions — what investors watch next week

Novo Nordisk stock jumps on Wegovy pill prescriptions — what investors watch next week

Novo Nordisk shares surged 6.49% to 388.90 Danish crowns Friday after early U.S. prescription data for its new Wegovy pill and UK approval of a higher Wegovy dose. U.S. retail pharmacies filled 3,071 Wegovy pill prescriptions in the first four days, not counting online sales. Novo’s ADRs rose 0.74% in New York. Investors await the company’s earnings report on Feb. 4.
18 January 2026
····
Pfizer stock slips into MLK Day break as FDA fast-track fears and key dates loom

Pfizer stock slips into MLK Day break as FDA fast-track fears and key dates loom

Pfizer shares fell 0.93% to $25.65 Friday amid industry concerns over a White House-backed fast FDA review program, Reuters reported. The company reaffirmed its 2026 revenue forecast and set its next dividend at $0.43 per share, with an ex-dividend date of Jan. 23. U.S. markets will close Monday for Martin Luther King Jr. Day. Pfizer’s quarterly results are due Feb. 3.
18 January 2026
·····
Novo Nordisk stock rallies: Wegovy pill scripts and UK higher-dose nod put NOVO-B back in play

Novo Nordisk stock rallies: Wegovy pill scripts and UK higher-dose nod put NOVO-B back in play

Novo Nordisk A/S Class B shares surged 6.5% to 388.9 Danish crowns Friday in Copenhagen after early U.S. prescription data for the new Wegovy pill surfaced and Britain approved a higher Wegovy dose for certain obesity patients. Trading volume reached 13.9 million shares. IQVIA data showed 3,071 U.S. retail prescriptions for the pill in its first four days, not counting online orders.
17 January 2026
·····
Roche stock price in focus: Goldman flips to neutral as ROG heads into Jan. 29 results

Roche stock price in focus: Goldman flips to neutral as ROG heads into Jan. 29 results

Roche shares closed up 0.93% at 348.90 francs Friday after Goldman Sachs raised its rating to neutral and boosted its price target to 365 francs, citing lower-risk clinical catalysts in 2026. UBS lifted its target to 384 francs, while Deutsche Bank held at 325. The SMI fell 0.5%. Swiss markets reopen Monday.
17 January 2026
·····
Eli Lilly stock price in focus as FDA slips obesity pill deadline — what to watch in LLY next week

Eli Lilly stock price in focus as FDA slips obesity pill deadline — what to watch in LLY next week

Eli Lilly shares rose 0.5% to $1,038.40 Friday as the FDA set April 10 as the new target date for a decision on its experimental weight-loss pill. The agency delayed review timelines for several drugs, including Lilly’s, under its fast-track program. Novo Nordisk’s new Wegovy pill saw about 3,071 U.S. prescriptions in its first four days, according to IQVIA data.
17 January 2026
·····
1 … 11 12 13 14 15 … 56

Stock Market Today

Meta stock faces an AI split: ad gains vs a $135 billion bill

Meta stock faces an AI split: ad gains vs a $135 billion bill

7 February 2026
Meta shares dropped 1.3% to $661.46 on Friday after the company projected 2026 capital spending of up to $135 billion, raising investor concerns over cash flow. Meta reported Q4 revenue of $59.89 billion, up 24% year-over-year, with ad impressions rising 18%. Analysts remain divided on whether AI-driven ad gains can offset the steep spending ramp.
IAG share price jumps toward a 52-week peak — what to watch before London reopens

IAG share price jumps toward a 52-week peak — what to watch before London reopens

7 February 2026
IAG shares rose 4.33% to 438.50 pence Friday, near their 52-week high, ahead of full-year results due later this month. The company reported 162,073,135 treasury shares and total voting rights of 4,565,128,012. Brent crude fell 2.2% Thursday to $67.93 a barrel. South Europe Ground Services logged 712,340 operations in 2025 and seeks approval to operate in Portugal.
Go toTop